Sat, Dec 20, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

EuroHedge awards: BlueCrest, Brevan Howard, Gartmore, Jabre and Lansdowne lead winners

Monday, January 25, 2010
Opalesque Industry Updates - BlueCrest, Brevan Howard, Jabre Capital and Lansdowne led the line-up of winners at the annual EuroHedge Awards last night – which were announced at a big hedge fund industry dinner and awards ceremony held at London’s Grosvenor House Hotel.

Jabre Capital won the Fund of the Year award with its Jabcap Multi-Strategy Fund, while BlueCrest won the Management Firm of the Year award for the second year in a row – and for an unprecedented third time.

Brevan Howard and the Lansdowne Global Financials Fund were the winners of the two Long Term Performance awards – which are based on the best risk-adjusted returns by hedge funds over a five-year period.

Gartmore was also a big winner on the night – with three of its AlphaGen range of long/short equity funds winning awards (for Volantis in Small-Cap Equity, Tucana in European Equity and Rhocas in Global Equity).

And Pharo – the emerging markets and macro trading firm led by Guillaume Fonkenell – also won two awards for the year, with Pharo Trading winning in Emerging Markets and the Pharo Macro flagship winning the Global Macro award.

The EuroHedge Awards for 2009, now in their ninth year, paid recognition to those funds that had achieved the best risk-adjusted performance across a range of strategy areas in an exceptional year of recovery and returns for hedge funds after the problems of 2008.

Jabcap Multi-Strategy, managed from Geneva by former GLG manager Philippe Jabre, beat off strong competition from a high-quality shortlist of contenders for Fund of the Year – comprising BlueCrest Capital International, BlueGold Global, Brevan Howard, Lansdowne UK Equity and Pharo Trading – while the firm’s Jabcap Global Convertible fund won the award for Convertible & Volatility Strategies.

In winning the coveted Management Firm of the Year award for a third time, BlueCrest emerged victorious from a strong shortlist of leading groups comprising Brevan Howard, Brummer & Partners, Gartmore, Jabre Capital, Lansdowne and Marshall Wace – all of which achieved multiple award nominations for their performance in 2009.

First-time winners included GLG Alpha Select in UK Equity, Zebedee Focus for European Equity (for funds with assets below $500m), Sloane Robinson Global Emerging in Emerging Market Equity, GSA Capital International in Equity Market-Neutral & Quant Strategies, York European in Event-Driven, Fortelus in Credit & Distressed and CQS Directional Opportunities in Multi-Strategy.

Pelagus Capital won the award for Global Fixed Income for a second year in succession, while the Commodities award was shared by Armajaro Commodities and BlueGold Global (which had won a New Fund of the Year award the previous year) and the Managed Futures & Currency award was won by IKOS G10 Currency.

The New Fund of the Year in equity strategies was Marshall Wace Global Opportunities, while the winner of the award for best New Fund of the Year in relative value and macro strategies was Numen Credit Opportunities.

Over 800 people attended the EuroHedge Awards gala dinner, including most of the leading managers and investors in the European hedge fund industry.

The complete list of winners in the 22 award categories was:

UK EQUITY
GLG Alpha Select

SMALL CAP
AlphaGen Volantis

EUROPEAN EQUITY (under $500m)
Zebedee Focus

EUROPEAN EQUITY (over $500m)
AlphaGen Tucana

GLOBAL EQUITY
AlphaGen Rhocas

EMERGING MARKET EQUITY
SR Global Emerging

EQUITY MARKET NEUTRAL & QUANT STRATEGIES
GSA Capital International

EVENT DRIVEN
York European Focus

CONVERTIBLES & VOLATILITY STRATEGIES
Jabcap Global Convertible

FIXED INCOME
Pelagus Capital

CREDIT & DISTRESSED
Fortelus Special Situations

EMERGING MARKETS (DEBT & MACRO)
Pharo Trading

COMMODITIES
Armajaro Commodities
BlueGold Global

MANAGED FUTURES & CURRENCY
IKOS G10 Currency

GLOBAL MACRO
Pharo Macro

MULTI-STRATEGY
CQS Directional Opportunities

NEW FUND OF THE YEAR - EQUITY STRATEGIES
Marshall Wace Global Opportunities

NEW FUND OF THE YEAR - RELATIVE VALUE & MACRO
Numen Credit Opportunities

LONG TERM PERFORMANCE – EQUITY STRATEGIES
Lansdowne Global Financials

LONG TERM PERFORMANCE – RELATIVE VALUE & MACRO
Brevan Howard

MANAGEMENT FIRM OF THE YEAR
BlueCrest Capital Management

FUND OF THE YEAR
Jabcap Multi-Strategy

Corporate website: Source

- FG

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und